Berberine drug interactions: which combinations were tested in people?
The clearest human test is with cyclosporine, a drug that prevents transplant rejection: in kidney transplant recipients, adding berberine raised cyclosporine blood levels.[1][2] In healthy men, 2 weeks of berberine slowed three liver enzymes that break down many common medicines.[4] Diabetes trials also measured blood sugar when berberine was added to treatment, which matters for anyone taking glucose-lowering medicines.[3]
Studies in people
| Medicine | Study | What was measured | Result |
|---|---|---|---|
| Cyclosporine | Randomized trial, 104 kidney transplant recipients, berberine 0.2 g three times a day for 3 months, or none | Cyclosporine trough blood level | 29.3% higher at the end with berberine than without[2] |
| Cyclosporine | 6 transplant recipients, before and after 12 days of berberine | Total cyclosporine exposure (AUC) | Up 34.5%[2] |
| Test drugs for five liver enzymes (midazolam, dextromethorphan, losartan, omeprazole, caffeine) | Randomized crossover trial, healthy men, berberine 300 mg three times a day for 2 weeks | Blood and urine levels of the test drugs | Midazolam exposure up 40%; the dextromethorphan marker up ninefold and the losartan marker doubled; no statistically significant difference for omeprazole or caffeine[4] |
Blood sugar studies
In these two groups of one pilot study, metformin was the comparison treatment, not a measured interaction; the results do not show that the two are interchangeable.[3]
| Group | Study | What was measured | Result |
|---|---|---|---|
| Metformin | 36 adults with new type 2 diabetes, berberine or metformin, 0.5 g three times a day, 3 months | HbA1c and blood sugar | Similar lowering in both groups; HbA1c 9.5% to 7.5% with berberine[3] |
| Existing diabetes treatment | 48 adults with poorly controlled type 2 diabetes added berberine, 3 months | HbA1c, fasting insulin | HbA1c 8.1% to 7.3%[3] |
How to read these results
- Cyclosporine levels rose in both groups. Trough levels went up 88.9% with berberine and 64.5% without it, so part of the rise was not due to berberine; the comparison between groups is the result to read.[2]
- The authors' explanation. They suggest berberine slows the breakdown of cyclosporine through the liver and gut enzyme CYP3A4; the study measured blood levels, not the enzyme.[2]
- The diabetes trials were not interaction studies. They measured how blood sugar changed; they did not test whether berberine changes the level of metformin or other diabetes drugs in the blood.[3]
- Which enzymes. The authors concluded berberine lowered the activity of CYP2D6, CYP2C9 and CYP3A4 and that drug interactions should be considered.[4]
What to do with this
NCCIH advises talking with your health care provider if you take medicine and are considering berberine.[1] The human data point to three groups in particular: cyclosporine, where blood levels were measured; medicines broken down by CYP2D6, CYP2C9 or CYP3A4; and medicines that lower blood sugar.[1][2][3][4]
Before you use berberine
- Pregnancy, breastfeeding and infants. NCCIH states that berberine is likely to be unsafe for infants and may be unsafe during pregnancy or breastfeeding.[1]
- Check the daily amount. See the extract and berberine amount on a label.
Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.
More about berberine
- Berberine guide
- Berberine side effects: what studies and NCCIH report
- Does berberine help weight loss? What the trials measured
- Do berberine patches work? What has been tested
- What is dihydroberberine, and how is it different from berberine?
- Berberine phytosome and liposomal berberine: what the absorption studies measured
- Berberine timing in human studies
- Berberine and blood sugar: what trials measured
- Berberine amounts on US supplement labels
- Berberine and cholesterol: what studies measured
Sources
- NCCIH. Berberine and Weight Loss: What You Need To Know. https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know ↩
- Wu X et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol, 2005;61:567–572. https://doi.org/10.1007/s00228-005-0952-3 ↩
- Yin J et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 2008;57:712–717. https://doi.org/10.1016/j.metabol.2008.01.013 ↩
- Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol, 2012;68:213–217. https://doi.org/10.1007/s00228-011-1108-2 ↩
You may quote, republish or translate this article under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/): credit "Verateca", link to this page and indicate changes, including translations. Quotes from NIH, FDA and other sources, label texts and prices are not covered by this license.